Evidence map›Paper›PMID 26583493›Full record

ArticleJournal of clinical neuromuscular disease2015

Expanding Phenotype of VRK1 Mutations in Motor Neuron Disease.

Thy P Nguyen, Suur Biliciler, Wojciech Wiszniewski, Kazim Sheikh

Abstract readCase Reports
In one paragraph

Article in Journal of clinical neuromuscular disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. NovelNeurology. Genetics · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. A novelAnnals of clinical and translational neurology · 2019
    Article
  15. Article
  16. Recent advances in the genetic neuropathies.Current opinion in neurology · 2016
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Thy P Nguyen*Department of Neurology, University of Texas Health Science Center at Houston, Houston, TX; and †Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX.
Suur Biliciler
Wojciech Wiszniewski
Kazim Sheikh
The University of Texas Health Science Center at Houston · USBaylor College of Medicine · US

Funding

Pathogenesis of Anti-ganglioside Antibody-Mediated NeuropathiesR01NS042888 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SHEIKH, KAZIM A · 2002 to 2016
$4.1M
Biologic effects of anti-ganglisiode antibodiesR01NS054962 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SHEIKH, KAZIM A · 2007 to 2018
$3.3M
Genome analysis to elucidate molecular mechanisms for peripheral neuropathiesK23NS078056 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI WISZNIEWSKI, WOJCIECH KRZYSZTOF · 2012 to 2016
$783k
Modulation of FcRn: A strategy to prevent autoantibody-mediated nerve injuryR21NS087467 · NINDS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SHEIKH, KAZIM A · 2014 to 2015
$380k
NINDS NIH HHS K23 NS078056NINDS NIH HHS K23NS078056NINDS NIH HHS R01 NS042888NINDS NIH HHS R01 NS054962NINDS NIH HHS R01NS42888NINDS NIH HHS R01NS54962NINDS NIH HHS R21 NS087467NINDS NIH HHS R21NS087467
6 · The paper itself

Abstract

objectiveIn the past decade, hereditary forms of motor neuron disease (spinal muscular atrophy and/or amyotrophic lateral sclerosis) are increasingly identified. As advanced genetic testing is performed, molecular diagnosis can be obtained. Identifying new gene mutations can lead to further understanding of disease. METHODS AND

resultsWe report a single case of a patient with early-onset amyotrophic lateral sclerosis, evaluated at University of Texas Health Houston Science Center from 2011-2014. Initial genetic testing did not reveal an etiology in this patient. Through whole-exome sequencing, a VRK1 mutation was identified. CONCLUSIONS AND RELEVANCE: We identify a possible new cause of hereditary amyotrophic lateral sclerosis, VRK1 mutation. This case report also expands the phenotypic spectrum of this mutation in neurologic diseases.

Indexed as

AdultComputational BiologyGenetic TestingHumansIntracellular Signaling Peptides and ProteinsMaleMotor Neuron DiseaseMuscle, SkeletalMutationPhenotypeProtein Serine-Threonine KinasesIntracellular Signaling Peptides and ProteinsProtein Serine-Threonine KinasesVRK1 protein, human

Identifiers

PMID26583493
PMCPMC4829393
OpenAlexW2438918770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.